Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EGFR (del 746-750) (Homo sapiens (Human)) | BDBM504402![]() (US11040984, Compound 2) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 16.5 | n/a | n/a | n/a | n/a | n/a | n/a |
MEDSHINE DISCOVERY INC. US Patent | Assay Description Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy... | US Patent US11040984 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EGFR (del 746-750) (Homo sapiens (Human)) | BDBM504415![]() (US11040984, Compound 30) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0520 | n/a | n/a | n/a | n/a | n/a | n/a |
MEDSHINE DISCOVERY INC. US Patent | Assay Description Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy... | US Patent US11040984 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor (Homo sapiens (Human)) | BDBM504415![]() (US11040984, Compound 30) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0210 | n/a | n/a | n/a | n/a | n/a | n/a |
MEDSHINE DISCOVERY INC. US Patent | Assay Description Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy... | US Patent US11040984 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EGFR (del 746-750) (Homo sapiens (Human)) | BDBM504411![]() (US11040984, Compound 13) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0520 | n/a | n/a | n/a | n/a | n/a | n/a |
MEDSHINE DISCOVERY INC. US Patent | Assay Description Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy... | US Patent US11040984 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor (Homo sapiens (Human)) | BDBM504416![]() (US11040984, Compound 33) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.114 | n/a | n/a | n/a | n/a | n/a | n/a |
MEDSHINE DISCOVERY INC. US Patent | Assay Description Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy... | US Patent US11040984 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EGFR (del 746-750) (Homo sapiens (Human)) | BDBM504405![]() (US11040984, Compound 4) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 55.4 | n/a | n/a | n/a | n/a | n/a | n/a |
MEDSHINE DISCOVERY INC. US Patent | Assay Description Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy... | US Patent US11040984 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor (Homo sapiens (Human)) | BDBM504412![]() (US11040984, Compound 18) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.0150 | n/a | n/a | n/a | n/a | n/a | n/a |
MEDSHINE DISCOVERY INC. US Patent | Assay Description Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy... | US Patent US11040984 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor (Homo sapiens (Human)) | BDBM504413![]() (US11040984, Compound 23) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0380 | n/a | n/a | n/a | n/a | n/a | n/a |
MEDSHINE DISCOVERY INC. US Patent | Assay Description Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy... | US Patent US11040984 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor (Homo sapiens (Human)) | BDBM504410![]() (US11040984, Compound 12) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0170 | n/a | n/a | n/a | n/a | n/a | n/a |
MEDSHINE DISCOVERY INC. US Patent | Assay Description Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy... | US Patent US11040984 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EGFR (del 746-750) (Homo sapiens (Human)) | BDBM504412![]() (US11040984, Compound 18) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0500 | n/a | n/a | n/a | n/a | n/a | n/a |
MEDSHINE DISCOVERY INC. US Patent | Assay Description Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy... | US Patent US11040984 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EGFR (del 746-750) (Homo sapiens (Human)) | BDBM504416![]() (US11040984, Compound 33) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.290 | n/a | n/a | n/a | n/a | n/a | n/a |
MEDSHINE DISCOVERY INC. US Patent | Assay Description Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy... | US Patent US11040984 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor(L858R) (Homo sapiens (Human)) | BDBM504403![]() (US11040984, Compound 3) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a |
MEDSHINE DISCOVERY INC. US Patent | Assay Description Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy... | US Patent US11040984 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor(L858R) (Homo sapiens (Human)) | BDBM504405![]() (US11040984, Compound 4) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 30.1 | n/a | n/a | n/a | n/a | n/a | n/a |
MEDSHINE DISCOVERY INC. US Patent | Assay Description Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy... | US Patent US11040984 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor (Homo sapiens (Human)) | BDBM504408![]() (US11040984, Compound 6) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.0150 | n/a | n/a | n/a | n/a | n/a | n/a |
MEDSHINE DISCOVERY INC. US Patent | Assay Description Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy... | US Patent US11040984 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor (Homo sapiens (Human)) | BDBM504411![]() (US11040984, Compound 13) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0160 | n/a | n/a | n/a | n/a | n/a | n/a |
MEDSHINE DISCOVERY INC. US Patent | Assay Description Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy... | US Patent US11040984 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor (Homo sapiens (Human)) | BDBM504414![]() (US11040984, Compound 25) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0220 | n/a | n/a | n/a | n/a | n/a | n/a |
MEDSHINE DISCOVERY INC. US Patent | Assay Description Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy... | US Patent US11040984 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EGFR (del 746-750) (Homo sapiens (Human)) | BDBM504414![]() (US11040984, Compound 25) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0690 | n/a | n/a | n/a | n/a | n/a | n/a |
MEDSHINE DISCOVERY INC. US Patent | Assay Description Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy... | US Patent US11040984 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Epidermal growth factor receptor(L858R) (Homo sapiens (Human)) | BDBM504402![]() (US11040984, Compound 2) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 48.1 | n/a | n/a | n/a | n/a | n/a | n/a |
MEDSHINE DISCOVERY INC. US Patent | Assay Description Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy... | US Patent US11040984 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EGFR (del 746-750) (Homo sapiens (Human)) | BDBM504408![]() (US11040984, Compound 6) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0700 | n/a | n/a | n/a | n/a | n/a | n/a |
MEDSHINE DISCOVERY INC. US Patent | Assay Description Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy... | US Patent US11040984 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EGFR (del 746-750) (Homo sapiens (Human)) | BDBM504410![]() (US11040984, Compound 12) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0850 | n/a | n/a | n/a | n/a | n/a | n/a |
MEDSHINE DISCOVERY INC. US Patent | Assay Description Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy... | US Patent US11040984 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EGFR (del 746-750) (Homo sapiens (Human)) | BDBM504413![]() (US11040984, Compound 23) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.170 | n/a | n/a | n/a | n/a | n/a | n/a |
MEDSHINE DISCOVERY INC. US Patent | Assay Description Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy... | US Patent US11040984 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
EGFR (del 746-750) (Homo sapiens (Human)) | BDBM504403![]() (US11040984, Compound 3) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0200 | n/a | n/a | n/a | n/a | n/a | n/a |
MEDSHINE DISCOVERY INC. US Patent | Assay Description Buffer formulation: a buffer consisted of 50 mM HEPES (pH 7.5), 0.01% BSA, 5 mM MgCl2, 0.1 mM Orthovanadate. After the buffer was formulated, an enzy... | US Patent US11040984 (2021) | |||||||||||
More data for this Ligand-Target Pair |